In June 2021, the FDA approved semaglutide (Wegovy), a once-weekly injection, for chronic weight management in adults when used in combination with a healthy diet and exercise. The medication had made headlines before its approval when the manufacturer reported 15% to 18% weight loss findings during clinical trials. This is higher than we tend to see with other weight loss medications. Since then, semaglutide has also been approved for chronic weight management in adolescents ages 12 and older. So, is semaglutide right for you? While it may work better than some other weight loss medications, there are other factors to consider.